Sabby Management’s Cellectar Biosciences CLRB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,422	Closed	-$508K	–	190
2021 Q2	$508K	Buy	1,422 +125	+10%	+$54.2K	0.11%	109
2021 Q1	$626K	Sell	1,297 -366	-22%	-$218K	0.46%	97
2020 Q4	$1.04M	Buy	+1,663	New	+$764K	1%	51
2017 Q1	–	Sell	-108	Closed	-$395K	–	286
2016 Q4	$395K	Buy	+108	New	+$586K	0.12%	212
2016 Q2	–	Sell	-24	Closed	-$242K	–	306
2016 Q1	$242K	Sell	24 -5	-17%	-$77.4K	0.05%	253
2015 Q4	$633K	Buy	29 +16	+123%	+$679K	0.21%	220
2015 Q3	$751K	Sell	13 -6	-32%	-$546K	0.15%	269
2015 Q2	$1.64M	Sell	19 -3	-14%	-$262K	0.41%	185
2015 Q1	$2.02M	Buy	22 +1	+5%	+$80.3K	0.56%	145
2014 Q4	$1.92K	Sell	21 -3	-13%	-$231K	0.14%	129
2014 Q3	$1.66K	Buy	+24	New	+$2.07M	0.19%	127